Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Automating neoantigen selection for personalized cancer vaccine design.

medRxiv : the preprint server for health sciences·2026
Same author

pVACtools v6: A comprehensive suite for neoantigen prediction, visualization, and therapy design.

ArXiv·2026
Same author

Individualised N-terminal Pro-B-type Natriuretic Peptide Thresholds for the Diagnosis of Heart Failure: A Proof-of-Concept Study.

Cureus·2026
Same author

Long-read cDNA sequencing reveals novel isoforms and spliceosome-mutant-enriched transcripts in AML and MDS.

bioRxiv : the preprint server for biology·2026
Same author

Cardio-oncology research prioritisation in the United Kingdom: national surveys of health care professionals, patients and carers.

Cardio-oncology (London, England)·2026
Same author

Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trial.

Nature cancer·2026

Related Experiment Video

Updated: Dec 10, 2025

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

11.0K

HPV-EM: an accurate HPV detection and genotyping EM algorithm.

Matthew J Inkman1, Kay Jayachandran1, Thomas M Ellis1,2

  • 1Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO, 63108, USA.

Scientific Reports
|September 2, 2020
PubMed
Summary

A new algorithm, HPV-EM, accurately identifies human papillomavirus (HPV) genotypes, improving cancer research and diagnostics. This advance aids in understanding HPV

More Related Videos

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

12.8K
RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

27.9K

Related Experiment Videos

Last Updated: Dec 10, 2025

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

11.0K
Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

12.8K
RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

27.9K

Area of Science:

  • Genomics
  • Infectious Disease Research
  • Oncology

Background:

  • Accurate human papillomavirus (HPV) genotyping is essential for epidemiology, vaccine development, and cancer research.
  • Current HPV genotyping methods detect less than 25% of known genotypes and struggle with low-risk or mixed infections.
  • Existing algorithms face challenges with repetitive and homologous sequences, limiting genotyping accuracy.

Purpose of the Study:

  • To develop an optimized algorithm for accurate HPV genotyping, addressing limitations of current methods.
  • To improve the detection of diverse HPV genotypes, including those in low-risk or mixed infections.
  • To enhance the analysis of HPV in cancer research, particularly for cervical and head and neck cancers.

Main Methods:

  • Development of an optimized expectation-maximization algorithm, named HPV-EM, to handle repetitive sequencing reads.
  • Benchmarking HPV-EM using cell line data and The Cancer Genome Atlas (TCGA) cervical cancer data.
  • Validation of HPV-EM using DNA tiling data from an institutional cervical cancer cohort.

Main Results:

  • HPV-EM achieved 97-100% accuracy on cell line and TCGA cervical cancer datasets.
  • Validation on an institutional cohort demonstrated 96.5% accuracy.
  • The algorithm revealed HPV genotypic differences associated with recurrence and patient outcomes in cervical and head and neck cancers.

Conclusions:

  • The developed HPV-EM algorithm significantly improves the accuracy of HPV genotyping.
  • HPV-EM effectively addresses challenges posed by repetitive sequences in genomic data.
  • This advancement has implications for understanding HPV's role in cancer recurrence and patient outcomes.